Investing Profile

Milad Alucozai

InvestorVCFounderAngel
Head of Life Sciences & Deep Tech at BoxOne Ventures
boxone.xyz/life-sciencesSan Francisco, California
Photo of Milad Alucozai, Investor at BoxOne Ventures
Your Intro Paths to Milad Alucozai

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Milad is a member of
Accenture Network
75 CONNECTIONS
Purdue University Network
40 CONNECTIONS
Creative Destruction Lab Network
17 CONNECTIONS
Harvard University Network
14 CONNECTIONS

Find Milad Alucozai on

cb
Current Investing Position
BoxOne Ventures Investor
Investment Range
$100K - $1M
Sweet Spot
$300K
Investments On Record
53

Milad Alucozai is on these Sector & Stage Rankings

Milad Alucozai's Investments On Record (41)

CompanyStageDateRound SizeTotal Raised
Axonis Therapeutics
Series AOct 2024$120M
SeedJul 2021$5M
$120M
Co-investors: Rebecca Allan (BoxOne Ventures), Jonathan Leff (Sofinnova Investments)
Future Fields
Series AFeb 2023$11M
$13M
Co-investors: Kira Noodleman (BEE Partners), Jim Adler (Toyota Ventures), Dave Messina (Pioneer Fund)
Eigen Therapeutics
SeedDec 2022$7M
$7M
Co-investors: Ludwig Schulze (Alumni Ventures ), Josh Kopelman (First Round Capital), Supachai Kid Parchariyanon (SeaX Ventures), Matthew De Silva (Builders VC), Kevin Mahaffey (SNR), Jano Búza (ZAKA Ventures), Varsha Rao
Wayfinder Biosciences
SeedOct 2022$4M
$4.3M
Co-investors: Po Bronson (SOSV), Lucy Wang (Divergent Capital), Nicholas Chirls (Asylum Ventures)
Seqera
Series AOct 2022$21M
SeedSep 2021$6M
Pre SeedMar 2019$110K
$27M
Co-investors: Jason Schneider (Addition), Kirill Tasilov (Talis Capital), Dominik Tobschall (backtrace capital), Manuel Grossmann (Amino Collective)
Arpeggio Bio
Series ASep 2022$17M
$20M
Co-investors: Matthew De Silva (Builders VC), Amit Mehta (Builders VC), Alice Zhang
Notable Labs
Series BJul 2022
Series ASep 2017$15M
$55M
Co-investors: Chris Sklarin (Alumni Ventures ), Anton Simunovic (Alumni Ventures ), Jim Kim (Builders VC), John Noonan (Lifeforce Capital), Kevin Mahaffey (SNR), Ramanan Raghavendran (AMASIA)
Character Biosciences
Series AMay 2022$18M
$120M
Co-investors: Cain McClary (KdT Ventures), John Noonan (Lifeforce Capital), Jonathan Roosevelt (Industry Ventures), Shane Neman

most interested in

I actively invest in early-stage biology, healthcare, and deep tech companies

Milad Alucozai's Experience

Venture Partner Entrepreneur First2020 - Present
External Advisor AstraZeneca2020 - Present
Executive Expert & Mentor Harvard University2020 - Present
Mentor Creative Destruction Lab2019 - Present
Chief Business Officer Mekonos2018 - Present
Business Advisor Numerate2018 - 2020
Chief Business Officer Corstem2018 - 2020
Global Portfolio & Delivery Lead Accenture2016 - 2018
Various Research Roles Purdue University2006 - 2015

Milad Alucozai's Education

Purdue University Bachelors of Science Neuroscience & Biomedical Engineering